These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16317320)

  • 1. Urinary hesitancy and retention caused by ziprasidone.
    Xomalis D; Bozikas VP; Garyfallos G; Nikolaidis N; Giouzepas J; Fokas K
    Int Clin Psychopharmacol; 2006 Jan; 21(1):71-2. PubMed ID: 16317320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
    Chung AK; Chua SE
    J Clin Psychopharmacol; 2007 Oct; 27(5):517-9. PubMed ID: 17873690
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary retention associated with ziprasidone: a case report.
    Mago R; Chism LM; Pinninti NR; Certa K
    J Clin Psychiatry; 2008 Mar; 69(3):499-500. PubMed ID: 18402503
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole associated urine retention in a male schizophrenia patient.
    Hsu WY; Chang TG; Chiu NY
    Gen Hosp Psychiatry; 2013; 35(6):680.e11-2. PubMed ID: 23932666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Retention Associated With Cariprazine: A Case Report.
    Kapulsky L; Brody BD
    Clin Neuropharmacol; 2018; 41(6):230-231. PubMed ID: 30273189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged erections associated with ziprasidone treatment: a case report.
    Reeves RR; Kimble R
    J Clin Psychiatry; 2003 Jan; 64(1):97-8. PubMed ID: 12590634
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ; Girgis RR; Gil R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
    Rossi A; Cañas F; Fagiolini A; Larmo I; Levy P; Montes JM; Papageorgiou G; Sturlason R; Zink M; Correll CU
    Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
    Tsai CF; Tsai SJ; Hwang JP
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):797-9. PubMed ID: 16035110
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziprasidone as a possible cause of cleft palate in a newborn.
    Peitl MV; Petrić D; Peitl V
    Psychiatr Danub; 2010 Mar; 22(1):117-9. PubMed ID: 20305605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mania associated with initiation of ziprasidone.
    Nolan BP; Schulte JJ
    J Clin Psychiatry; 2003 Mar; 64(3):336. PubMed ID: 12716277
    [No Abstract]   [Full Text] [Related]  

  • 13. A case report with ziprasidone-induced catatonic symptoms.
    Markham-Abedi C; McNeely C; de Leon J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):476-7. PubMed ID: 18070860
    [No Abstract]   [Full Text] [Related]  

  • 14. A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.
    Akkaya C; Sarandol A; Sivrioglu EY; Kotan Z; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1535-8. PubMed ID: 16820256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study.
    Vieweg WV; Hasnain M
    Am J Psychiatry; 2011 Jun; 168(6):650-1; author reply 651. PubMed ID: 21642483
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute dystonia after initial doses of ziprasidone: a case report.
    Yumru M; Savas HA; Selek S; Savas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone-associated mania in Korean schizophrenic patient.
    Park YM; Lee SH; Lee HJ; Kim H; Lee KJ; Kang SG
    J Clin Psychopharmacol; 2008 Dec; 28(6):711-3. PubMed ID: 19011448
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
    Margetic B; Aukst-Margetic B
    World J Biol Psychiatry; 2007; 8(2):131-2; author reply 133-4. PubMed ID: 17455107
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone-associated mania: a review and report of 2 additional cases.
    Keating AM; Aoun SL; Dean CE
    Clin Neuropharmacol; 2005; 28(2):83-6. PubMed ID: 15795551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.